Apollo Hospitals, India's leading healthcare provider, in its yet another initiative to bring the best healthcare practices to India, announced its plans to establish a Proton Therapy Center in India, the first of its kind across South East Asia, Africa and Australia. This launch, which marks the beginning of the next wave of advancement in radiation therapy in India, is worth approximately Rs. 400 crores, which covers the equipment and services supplied by Ion Beam Applications S.A. (IBA) to help establish the Apollo Proton Therapy Center including the long-term operation and maintenance contract.

Designed with state-of-the-art technology, IBA Proteus PLUS is clinically inspired to offer the possibility to configure the most appropriate combination of features to meet the individual needs of patients and provides a versatility to meet the clinical objectives of physicians. IBA will equip the Apollo Proton Therapy Center with its Proteus PLUS multi-room configuration which will include three treatment rooms with Uniform Scanning and Pencil Beam Scanning capabilities. IBA will also provide all dosimetry equipment to ensure the safest and fastest commissioning of the center so that patients can benefit from this technology starting in 2016. In addition to this, the Apollo Proton Therapy Center will have a significant portion of the facility dedicated to research and development that will partner with leading institutions across the world to foster innovation so as to make modern healthcare accessible and available for the nation.

Speaking on this new initiative, Dr. Prathap C Reddy, chairman of Apollo Hospitals Group said, "This new Proton Therapy facility will give patients access to the most advanced radiation therapy technology. Moreover, the center will become an International Proton Therapy Center of Reference in Asia, allowing us to further enhance our ability to provide superior cancer care and promote the benefits of proton therapy technology across the subcontinent."

Olivier Legrain, CEO of IBA, commented: "We are very excited to be making proton therapy available for the first time in India. The Indian healthcare market is growing rapidly and there is a significant need for innovative approaches to cancer therapy. Apollo Hospitals is one of Asia's leading healthcare providers and through our collaboration, IBA further strengthens its world leading position in proton therapy and will be at the forefront of delivering the latest in innovative cancer therapy to the Asia region."

With approximately 3 million people suffering from cancer in India and one million new cases being detected every year, there is a need for specialty cancer treatment hospitals. As most patients are diagnosed with advanced stage cancer, the demand for state-of-the-art cancer treatment is high. This Proton Therapy Centre, with its highly advanced technology, will be able to provide the best in class treatment for patients who suffer from cancer.

Proton therapy is increasingly considered the most advanced and targeted cancer treatment due to its superior dose distribution and fewer side effects. Protons deposit the majority of their effective energy within a precisely controlled range, directly within the tumor and sparing healthy surrounding tissue. It is used today to treat many cancers and is particularly appropriate in situations where treatment options are limited and conventional radiation therapy presents risks to patients. These situations include eye and brain cancers, tumors close to the brain stem and spinal cord, prostate, liver, lung and breast cancers, and pediatric cancers.

About Apollo Hospitals Enterprise Ltd. (AHEL)

It was in 1983 that Prathap C Reddy, M.D., made a pioneering endeavour by launching India's first corporate hospital - Apollo Hospitals in Chennai. Now, as Asia's largest and most trusted healthcare group, its presence includes over 8,500 beds across 50 hospitals, 1,350 pharmacies, 100 primary care and diagnostic clinics, 100 telemedicine units across 9 countries, medical business process outsourcing services, health insurance services, global projects consultancy, 15 colleges of nursing and hospital management and a research foundation with a focus on global clinical trials, epidemiological studies, stem cell and genetic research.

In a rare honor, the Government of India issued a commemorative stamp in recognition of Apollo's contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Prathap C. Reddy, MD, was conferred with the prestigious Padma Vibhushan in 2010. For more than 29 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.

For more information: www.iba-worldwide.com


Related Content

News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Treatment Planning

February 2, 2024 — RaySearch Laboratories announced that the number of radiotherapy centers that have chosen RayStation ...

Time February 02, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

January 11, 2024 — On January 9th, 2024, a scientific prototype for MRI-guided proton therapy was inaugurated in Dresden ...

Time January 11, 2024
arrow
News | Radiation Therapy

December 27, 2023 — Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center – Arthur G ...

Time December 27, 2023
arrow
Feature | Proton Therapy | By Christine Book

A University of Miami Radiation Oncology department summary noted: “In radiation oncology, the art of patient care meets ...

Time October 11, 2023
arrow
Videos | Proton Therapy

Tune in to ITN’s latest “One on One” video series with Michael Butkus, PhD, for insights into proton therapy ...

Time October 10, 2023
arrow
News | Proton Therapy

October 4, 2023 — RaySearch Laboratories AB has announced its expanded collaboration with P-Cure, aiming at enhancing ...

Time October 04, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
Subscribe Now